Biopharma Stock Soaring on Buyout News

Options traders are targeting AVEO at 17 times the intraday average volume

Laura McCandless

Deputy Editor

Oct 18, 2022 at 3:14 PM

Aveo Pharmaceuticals Inc (NASDAQ:AVEO) stock is soaring today, up 40.7% at $14.74 at last glance, after news that South Korean chemical company LG Chem plans to buy the biopharmaceutical name for $15 per share, or roughly $566 million, in an all-cash deal. The acquisition will expand LG's U.S. presence and propel it further into cancer development.

This bull gap has AVEO at its highest level since March of 2021. The stock was already moving higher before today's bull gap, though, thanks to its 60-day moving average. Year-to-date, the equity is up 215.6%. A short-term drop could be overdue, however, as AVEO's 14-day relative strength index (RSI) of 83.5 sits firmly in "overbought" territory.

AVEO's options pits are teeming with activity amid the news. So far, 8,145 calls and 1,165 puts have crossed the tape -- 17 times the volume typically seen at this point. The January 2023 15-strike call is the most popular, followed by the October 15 call, with new positions being opened at both.

Follow @Schaeffers

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!